Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on scPharmaceuticals, Raises Price Target to $12

SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $11 to $12.
byBenzinga Newsdesk
November 10, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Roanna Ruiz maintains scPharmaceuticals (NASDAQ:SCPH) with a Outperform and raises the price target from $11 to $12.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts